Funding Received
$7.6 Million in 2 Rounds from 5 Investors
Most Recent Funding
$3.7 Million Series B on February 26, 2008
Headquarters:
San Diego, CA
Description:
Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.
Categories:
Biotechnology
Website:
http://www.adnavance.com

Company Details

Update

Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company’s patented and ultra-sensitive metalized-DNA (M-DNA™) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    11494 Sorrento Valley Road, Suite H

    San Diego, CA 92121

    USA

Images (1)

Update
  • 137b0f9a19c005afee84a0d8df0a52b1